XMMO Fact Sheet: Invesco S&P MidCap Momentum ETF
Share
$130.99
close, Nov 18, 2026
Over the year to Nov 18, 2026, XMMO returned −0.3% in total and charged 0.34% a year.
- 1-year total return
- −0.3%
- to Nov 18, 2026
- Expense ratio
- 0.34%
- a year
- Net assets
- $6.1bn
- on Nov 17, 2026
- Net flow, last 5 trading days
- −$87.0m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
XMMO $9,967 −0.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−6.8%
3 months−17.7%
Year to date−4.9%
1 year−0.3%
3 years+61.6%
5 years+43.8%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Roivant Sciences Ltd4.28%
TechnipFMC PLC4.16%
ATI Inc4.12%
United Therapeutics Corp2.72%
Jazz Pharmaceuticals PLC2.69%
MKS Inc2.59%
TD SYNNEX Corp2.56%
HF Sinclair Corp2.56%
BrightSpring Health Services Inc2.42%
Reliance Inc2.24%
XMMO top ten by weight, 30.3% of the fund, of its 79 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P MidCap 400 Momentum Index · First traded Mar 3, 2005 · Benchmark Its own holdings, as of Nov 17, 2026